There's an article on cancer.org that sums up the current state of the DCA research pretty well.
Clinical trials take a _long_ time, and this is perhaps more true for medicine than it is for any other field. It is not surprising that preliminary indications reported in 2007, have not yet reached the market.
From what I've been able to gather, research on the topic progresses as you'd expect (it does not seem inhibited by a lack of interest from the medical establishment), and it even seems promising. The article linked to above references a 2010 study, which I do not have access to, but see the discussion in the cancer.org article for more on that study.